PDT Partners’s Transmedics TMDX Stock Holding History

PDT Partners’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-16,300	Closed	-$2.56M	–	833
2024 Q3	$2.56M	Buy	+16,300	New	+$2.51M	0.23%	148
2022 Q4	–	Sell	-6,100	Closed	-$255K	–	891
2022 Q3	$255K	Buy	+6,100	New	+$265K	0.04%	645

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PDT Partners's TMDX Position: Q4 2024 in Review

PDT Partners sold out of Transmedics (TMDX) in Q4 2024, closing a stake of 16,300 shares — an estimated $2.56M sold.

PDT Partners first reported a position in TMDX in Q3 2022 and held it in 2 quarters. The position peaked at $2.56M in Q3 2024. 315 funds tracked by Wall St. Rank hold TMDX as of Q4 2024.

PDT Partners reported no remaining Transmedics position as of Q4 2024 after selling out during the quarter.
PDT Partners sold 16,300 Transmedics shares in Q4 2024, an estimated $2.56M.
PDT Partners first reported a position in Transmedics in Q3 2022 and held it in 2 quarters.
PDT Partners's Transmedics position peaked at $2.56M in Q3 2024.
315 funds tracked by Wall St. Rank held Transmedics as of Q4 2024.

Based on PDT Partners's 13F filing for Q4 2024, filed 14 Feb 2025.